These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9238097

  • 1. Selenite nuclear cataract: review of the model.
    Shearer TR, Ma H, Fukiage C, Azuma M.
    Mol Vis; 1997 Jul 23; 3():8. PubMed ID: 9238097
    [Abstract] [Full Text] [Related]

  • 2. Changes in calpain II mRNA in young rat lens during maturation and cataract formation.
    Ma H, Shih M, Throneberg DB, David LL, Shearer TR.
    Exp Eye Res; 1997 Mar 23; 64(3):437-45. PubMed ID: 9196396
    [Abstract] [Full Text] [Related]

  • 3. Calpains: targets of cataract prevention?
    Biswas S, Harris F, Dennison S, Singh J, Phoenix DA.
    Trends Mol Med; 2004 Feb 23; 10(2):78-84. PubMed ID: 15102361
    [Abstract] [Full Text] [Related]

  • 4. Regional distribution of free calcium in selenite cataract: relation to calpain II.
    Hightower KR, David LL, Shearer TR.
    Invest Ophthalmol Vis Sci; 1987 Oct 23; 28(10):1702-6. PubMed ID: 2820891
    [Abstract] [Full Text] [Related]

  • 5. Biochemical changes in selenite cataract model measured by high-resolution MAS H NMR spectroscopy.
    Fris M, Tessem MB, Saether O, Midelfart A.
    Acta Ophthalmol Scand; 2006 Oct 23; 84(5):684-92. PubMed ID: 16965502
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evidence for apoptosis in the selenite rat model of cataract.
    Tamada Y, Fukiage C, Nakamura Y, Azuma M, Kim YH, Shearer TR.
    Biochem Biophys Res Commun; 2000 Aug 28; 275(2):300-6. PubMed ID: 10964662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro precipitation of rat lens crystallins by calpain I--a calpain requiring low amounts of calcium for activation.
    Shearer TR, Throneburg DB, Shih M.
    Ophthalmic Res; 1996 Aug 28; 28 Suppl 2():109-14. PubMed ID: 8883097
    [Abstract] [Full Text] [Related]

  • 12. Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice.
    Nakamura Y, Fukiage C, Shih M, Ma H, David LL, Azuma M, Shearer TR.
    Invest Ophthalmol Vis Sci; 2000 May 28; 41(6):1460-6. PubMed ID: 10798663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selenite cataract and its attenuation by vitamin E in Wistar rats.
    Mathew JP, Thomas VC, Thomas I.
    Indian J Ophthalmol; 2003 Jun 28; 51(2):161-70. PubMed ID: 12831147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro.
    Mathur P, Gupta SK, Wegener AR, Breipohl W, Ahrend MH, Sharma YD, Gupta YK, Vajpayee RB.
    Curr Eye Res; 2000 Dec 28; 21(6):926-33. PubMed ID: 11262616
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.